ORAGENICS INC — Director's Dealing 2011

Feb 15, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (ORNI)
CIK: 0001174940
Period of Report: 2011-02-11

Reporting Person: KOSKI FAMILY LP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-11	Common Stock	J	1208000	$.00	Disposed	1790000	Direct
2011-02-11	Common Stock	J	400000	$.00	Acquired	444666	Direct
2011-02-11	Common Stock	J	400000	$.00	Acquired	422666	Direct
2011-02-11	Common Stock	J	400000	$.00	Acquired	469666	Direct
2011-02-11	Common Stock	J	8000	$.00	Acquired	10000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70000	Indirect

Footnotes

F1: On February 11, 2011 the Koski Family Limited Partnership ("KFLP') authorized a distribution of 1,208,000 shares of Oragenics Inc. common stock to the KFLP's underlying partners Beverly Koski (through Koski Management, Inc.) Christine L. Koski, Robert C. Koski and Thomas L. Koski on a pro rata basis, in accordance with their ownership interests in the KFLP.

F2: Shares owned directly by the KFLP. Shares owned indirectly by Beverly Koski (through Koski Management, Inc. solely owned by Beverly Koski) , Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.

F3: Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F4: Shares owned directly by Oragenics Inc. director, Christine L. Koski.

F5: Shares owned directly by Oragenics Inc. director, Robert C. Koski.

F6: Shares owned directly by Thomas L. Koski.

F7: Shares owned by trusts of which Robert C. Koski is sole trustee. Such trusts are the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (10,000 shares); The Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (25,000 shares); The Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (25,000 shares); and The Robert Clayton Koski Trust for the benefit of Robert Edward Koski (10,000 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.

F8: Shares owned indirectly by Beverly Koski (through Koski Management, Inc).

F9: Share amounts reflected are after adjustment for the Issuer's 1 for 20 reverse stock split that occurred on September 24, 2010.